GLP-1 therapies are reshaping metabolic care at unprecedented speed — but alongside the headlines, clinicians are left navigating complex questions around long-term outcomes, sustainability, nutrition, and patient dependency.
This thought-leadership evening brings healthcare professionals together to explore how GLP-1s fit into modern metabolic care — without losing sight of physiology, behaviour, and long-term health.
We are delighted to welcome Dr David Unwin as our keynote speaker — a GP, internationally recognised educator, and one of the most trusted clinical voices in metabolic health. Known for his measured, evidence-led approach, Dr Unwin will explore how GLP-1 therapies can be used thoughtfully and responsibly, alongside nutrition-first strategies that protect metabolic resilience, muscle mass, and patient autonomy.
Rather than positioning GLP-1s as a silver bullet — or dismissing them outright — this keynote will challenge clinicians to think critically, ethically, and systemically about where these therapies belong in practice.
Keynote Speaker
Dr David Unwin
GP | International Leader in Metabolic Health
Dr Unwin is widely recognised for his balanced, evidence-based approach to metabolic care. In this keynote, he will explore where GLP-1 therapies sit within modern clinical practice, how nutrition remains foundational, and what sustainable metabolic care looks like beyond short-term interventions.
Panel Discussion
Following the keynote, an expert panel will broaden the conversation by examining:
-
Alternatives and adjuncts to GLP-1 therapies
-
Nutrition-first approaches to metabolic health
-
Long-term sustainability and patient independence
-
Practical considerations clinicians face in real-world practice
Whats included:
- Access to full event + Q&A
- Bowl food, Drinks, and Networking
- Exclusive Sponsor Discounts and goodybag
The evening will then open into an expert panel discussion, bringing together diverse clinical perspectives to explore alternatives, adjuncts, and nutrition-led strategies that support metabolic health beyond pharmacology alone. Together, we’ll examine what sustainable metabolic care really looks like — and how practitioners can design pathways that serve patients long after the prescription ends.
This is not a debate for headlines.
It’s a clinical conversation for clinicians and practitioners shaping the future of metabolic care.
